Skip to search formSkip to main contentSkip to account menu

Peru 15

Known as: Peru-15 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Cholera Vaccine
CholeraGarde

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2013
Review
2013
The state-of-the-art of approved and under-development cholera vaccines.
Review
2009
Review
2009
Development of Peru-15 (CholeraGarde®), a live-attenuated oral cholera vaccine: 1991–2009
Epidemics of severe dehydrating cholera are on the increase in resource-limited settings around the world. Adults, children and… 
2007
2007
Gateways to clinical trials.
1E10, 101M; AAV-ASPA, agomelatine, aliskiren fumarate, alvimopan hydrate, ambrisentan, apaziquone, axitinib; Becatecarin… 
Review
2006
Review
2006
Live attenuated oral cholera vaccines
Live, orally administered, attenuated vaccine strains of Vibrio cholerae have many theoretical advantages over killed vaccines. A… 
Highly Cited
2005
Highly Cited
2005
Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh.
BACKGROUND A live oral Vibrio cholerae O1 El Tor vaccine candidate, Peru-15, was studied for safety, immunogenicity, and… 
2005
2005
Gateways to clinical trials.
Gateways to Clinical Trials is a guide to the most recent clinical trials reported in current literature and congresses. The data… 
Review
2004
Review
2004
Peru-1 5 (AVANT).
Peru-15 is a single dose, recombinant cholera vaccine under development by AVANT Immunotherapeutics for the potential prevention… 
1998
1998
Replicating function of the RS1 element associated with Vibrio cholerae CTX phi prophage.
The RS1 element associated with Vibrio cholerae CTX phi prophage was cloned from an E1 Tor biotype Vibrio cholerae strain. We… 
1997
1997
Evaluation of Peru-15, a new live oral vaccine for cholera, in volunteers.
A new live oral cholera vaccine, Peru-15, was studied for safety, immunogenicity, and excretion in 2 groups of healthy volunteers… 
1997
1997
Comparison of alternative buffers for use with a new live oral cholera vaccine, Peru-15, in outpatient volunteers
During development of Peru-15, a new live oral vaccine for cholera, the role of buffer needed to be evaluated. Generally, oral… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)